Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.26 USD | -2.54% |
|
+29.24% | +84.01% |
15/07 | Transcript : Kymera Therapeutics, Inc. Presents at UBS Virtual Targeted Protein Degradation Day, Jul-15-2024 01:00 PM | |
09/07 | Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+84.01% | 297.53Cr | |
+23.59% | 4.8TCr | |
+0.11% | 4.24TCr | |
+43.96% | 4.15TCr | |
+25.91% | 3.16TCr | |
+19.44% | 2.86TCr | |
-4.47% | 2.8TCr | |
+51.34% | 1.46TCr | |
+43.72% | 1.41TCr | |
+2.03% | 1.26TCr |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Transcript : Kymera Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 09